论文部分内容阅读
Background. Silencing of the suppressor of cytokine signaling(SOCS-1) by aberrant methylation at the CpG island in the coding region gene has been reported in hepatocellular carcinoma(HCC). However, principally, it is methylation in the 5-noncoding region but not that in the coding region which determines the regulation of gene expression. Methods. Methylation-specific PCR was performed for the analysis of methylation status both in the 5-noncoding region and the CpG island of SOCS-1 from 22 HCC tissue samples with adjacent non-HCC tissue samples and from two cell lines. Results. Using primers in the CpG island, 9 of 22 HCC samples exhibited aberrant methylation of SOCS-1, while only 1 of 22 adjacent non-HCC samples did so.The unmethylation pattern was detected in 1 of 22 HCC and in 5 of 22 non-HCC samples. Thus, aberrant methylation of SOCS-1 was significantly associated with HCC (P = 0.0076 by Fisher s exact test). Using primers in the 5-noncoding region,aberrant methylation was observed in 12 of 22 HCC and in 2 non-HCC samples. The unmethylated pattern was observed in 5 of 22 HCC and in 10 of 22 non-HCC samples (P = 0.0042). There was no significant correlation between the methylation status of SOCS-1 and clinicopathological findings, such as the presence or absence of cirrhosis or the histological grade of HCC. Conclusions. Aberrant methylation of the SOCS-1 had a significant correlation with HCC. The rate of aberrant methylation was similar in the 5-noncoding region and in the CpG island. Aberrant methylation of SOCS-1 may be associated with hepatocarcinogenesis, although further studies are necessary.
Background. Silencing of the suppressor of cytokine signaling (SOCS-1) by aberrant methylation at the CpG island in the coding region gene has been reported in hepatocellular carcinoma (HCC). However, principally, it is methylation in the 5-noncoding region but not that in the coding region which determines the regulation of gene expression. Methods. Methylation-specific PCR was performed for the analysis of methylation status both in the 5-noncoding region and the CpG island of SOCS-1 from 22 HCC tissue samples with adjacent Non-HCC tissue samples and from two cell lines. Results. Using primers in the CpG island, 9 of 22 HCC samples rendered aberrant methylation of SOCS-1, while only 1 of 22 adjacent non-HCC samples did so. The unmethylation pattern was Detected in 1 of 22 HCC and in 5 of 22 non-HCC samples. Thus, aberrant methylation of SOCS-1 was significantly associated with HCC (P = 0.0076 by Fisher’s exact test). Using primers in the 5-noncoding region, aberrant methylation was o The unmethylated pattern was observed in 5 of 22 HCC and in 10 of 22 non-HCC samples (P = 0.0042). There was no significant correlation between the methylation status of SOCS -1 and clinicopathological findings, such as the presence of absence or cirrhosis or the histological grade of HCC. Conclusions. Aberrant methylation of the SOCS-1 had a significant correlation with HCC. The rate of aberrant methylation was similar in the 5-noncoding region and in the CpG island. Aberrant methylation of SOCS-1 may be associated with hepatocarcinogenesis, although further studies are necessary.